BioDrugs

1.5k papers and 36.1k indexed citations

About

The 1.5k papers published in BioDrugs in the last decades have received a total of 36.1k indexed citations. Papers published in BioDrugs usually cover Immunology (473 papers), Molecular Biology (353 papers) and Oncology (302 papers) specifically the topics of Biosimilars and Bioanalytical Methods (219 papers), Monoclonal and Polyclonal Antibodies Research (182 papers) and Rheumatoid Arthritis Research and Therapies (93 papers). The most active scholars publishing in BioDrugs are William R. Strohl, Francesco M. Veronese, Anna Mero, Gillian M. Keating, Ivana Jovčevska, Serge Muyldermans, Jeremy P. Bradshaw, Michael Naso, William L. Perry and Brian Tomkowicz.

In The Last Decade

BioDrugs

1.4k papers receiving 34.8k citations

Peers

BioDrugs
Comparison fields: 5 of 202
  • Molecular Biology 12.5k
  • Immunology 9.7k
  • Oncology 6.5k
  • Radiology, Nuclear Medicine and Imaging 4.9k
  • Genetics 3.3k
Replace International Reviews of Immunology with:
International Reviews of Immunology United States
Growth Factors United States
Immunological Investigations United States
Current Molecular Medicine United States
Angiogenesis United States
Immunotherapy United States
Translational research United States
Microcirculation United States
Immunopharmacology United States
BMC Immunology United States
International Reviews of Immunology United States View profile →
Citations per field, relative to BioDrugs
BioDrugs · 1×
Citations per year, relative to BioDrugs
BioDrugs · 1×

Countries where authors publish in BioDrugs

Since Specialization
Citations

This map shows the geographic impact of research published in BioDrugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in BioDrugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BioDrugs more than expected).

Fields of papers published in BioDrugs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in BioDrugs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in BioDrugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2026